Oger, J <br/><br/>
Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: the PRISMS study.  [electronic resource] 

 -  Journal of the neurological sciences  Oct 2005 
 - 45-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-510X 
<br/><br/><label>Standard No.: </label>10.1016/j.jns.2005.05.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cross-Over Studies<br/>Disability Evaluation<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Interferon Type I--administration & dosage<br/>Interferon beta-1a<br/>Interferon-beta--administration & dosage<br/>Magnetic Resonance Imaging<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Prospective Studies<br/>Recombinant Proteins<br/>Recurrence<br/>Research Design<br/>Treatment Outcome